Cargando…

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

BACKGROUND: Although systemic corticosteroid (SCS) treatment, irrespective of duration or dosage, is associated with adverse outcomes for patients with asthma, the longitudinal effects of this treatment on adverse outcomes, healthcare resource utilization (HCRU), and healthcare costs are unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voorham, Jaco, Xu, Xiao, Price, David B., Golam, Sarowar, Davis, Jill, Zhi Jie Ling, Joanna, Kerkhof, Marjan, Ow, Mandy, Tran, Trung N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587525/ https://www.ncbi.nlm.nih.gov/pubmed/29987879 http://dx.doi.org/10.1111/all.13556

Ejemplares similares

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
por: Price, David B, et al.
Publicado: (2018)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
por: Tran, Trung N, et al.
Publicado: (2021)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
por: Bleecker, Eugene R., et al.
Publicado: (2020)

Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma
por: Sullivan, Patrick W., et al.
Publicado: (2020)

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
por: Price, David B., et al.
Publicado: (2019)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study
por: Ebrahimoghli, Reza, et al.
Publicado: (2022)

Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care
por: Thickett, David, et al.
Publicado: (2020)

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease
por: Iyer, Neeraj N, et al.
Publicado: (2018)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids
por: Chan, James, et al.
Publicado: (2007)

Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
por: Thomas, Mike, et al.
Publicado: (2009)

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study
por: Voorham, Jaco, et al.
Publicado: (2020)

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
por: Voorham, Jaco, et al.
Publicado: (2018)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Corticosteroids in the treatment of acute asthma
por: Alangari, Abdullah A.
Publicado: (2014)

Asthma: beyond corticosteroid treatment
por: Marandi, Yasser, et al.
Publicado: (2013)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
por: De Jong, Hilda J.I., et al.
Publicado: (2020)

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
por: Bourdin, Arnaud, et al.
Publicado: (2018)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients
por: Qureshi, Zaina P., et al.
Publicado: (2021)

A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan
por: Inoue, Hiromasa, et al.
Publicado: (2019)

Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma
por: Price, David, et al.
Publicado: (2021)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
por: Price, David, et al.
Publicado: (2020)

An Incremental High-Utility Mining Algorithm with Transaction Insertion
por: Lin, Jerry Chun-Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_caq3ctncqidae6upa68jq1qsui